So he joined GSK
Vaccines in 2010, as a molecular biologist in the company's Antigen -
Specific Cancer Immunotherapeutic
program, which aims to harness the immune system for the development of well - tolerated cancer therapies.
Genomic data about individuals and groups might be consulted during disease outbreaks, in planning for public health
programs, or in developing new or assessing existing public health policies; for instance, where are the hotspots for infection (and are these associated with
specific pathogen or host genomics), where should
vaccines be deployed most urgently, which therapies should be offered to which genomic populations, and where should treatment
programs, isolation policies or public health control
programs be implemented to halt the spread of infections?